Characteristic | n (%) |
---|---|
Sex | Â |
Male | 46 (40.4) |
Female | 68 (59.6) |
Age | Â |
Mean +/− SD | 57.7 +/− 11.8 |
Median | 59.0 |
Range | 22-88 |
Primary tumour type | Â |
Breast | 36 |
NSCLC | 29 |
Melanoma | 9 |
Colorectal | 9 |
Renal Cell | 6 |
Oesophageal | 5 |
Gynaecological | 3 |
Sarcoma | 2 |
Prostate | 2 |
Head and Neck | 2 |
Thyroid | 1 |
Hepatocellular | 1 |
Unknown | 9 |
Primary tumour controlled | Â |
Yes | 94 (82.5 |
No | 20 (17.5) |
Extracerebral metastases | Â |
Yes | 66 (57.9) |
No | 48 (42.1) |
ECOG performance status | Â |
0 | 59 |
1 | 47 |
2 | 5 |
3 | 3 |
Recursive partitioning analysis | Â |
I | 26 |
II | 80 |
III | 8 |
Number of metastases | Â |
1 | 72 (63.2) |
2–3 | 22 (19.3) |
≥4 | 20 (17.5) |